# Can Adropin mitigate oxidative stress in heart failure with preserved ejection fraction?

Canonical source: https://retacompare.com/research/can-adropin-mitigate-oxidative-stress-in-heart-failure-with-preserved-ejection-fraction

Peptide Longevity Q&A · 2025-09-02


    Research indicates that Adropin can mitigate oxidative stress in heart failure with preserved ejection fraction (HFpEF) by activating the Nrf2/HO-1 signaling pathway. This leads to improved metabolic function and reduced cardiac hypertrophy and fibrosis, highlighting its potential therapeutic role.

 What the research shows

The study investigated the effects of Adropin in a preclinical model of heart failure with preserved ejection fraction (HFpEF). C57BL/6 mice were subjected to a high-fat diet and treated with NG-nitro-L-arginine methyl ester (L-NAME) to induce HFpEF. The research involved administering recombinant Adropin to these mice and assessing various parameters, including cardiac structure and function through echocardiography, metabolic status, and oxidative stress markers. The study found that Adropin supplementation improved metabolic parameters, reduced cardiac hypertrophy and fibrosis, and enhanced diastolic function. Additionally, the mechanism of action was linked to the activation of the Nrf2/HO-1 signaling pathway, which is crucial for regulating oxidative stress and apoptosis.

 Why it matters for longevity

The findings from this study are significant in the context of longevity, particularly as they relate to heart health. HFpEF is a common condition that affects a large number of older adults, contributing to morbidity and mortality. By targeting oxidative stress and metabolic dysregulation, Adropin has the potential to improve heart function and overall quality of life for patients with HFpEF. This suggests that interventions aimed at enhancing Adropin levels or mimicking its effects could be beneficial in promoting cardiovascular health and longevity, particularly in aging populations.

 Key findings at a glance

Adropin levels were significantly reduced in HFpEF mice.

Supplementation with Adropin improved glucose and lipid metabolism.

Adropin treatment reduced cardiac hypertrophy and fibrosis.

Activation of the Nrf2/HO-1 signaling pathway was observed with Adropin treatment.

Adropin knockout exacerbated metabolic disturbances and cardiac dysfunction.

 How Adropin works (background)

Adropin is a peptide that plays a crucial role in regulating cardiovascular and metabolic homeostasis. In the context of HFpEF, it appears to exert its effects through the activation of the Nrf2/HO-1 signaling pathway. This pathway is vital for the body's response to oxidative stress, promoting the expression of antioxidant enzymes and reducing markers of oxidative damage. By enhancing the body's antioxidant defenses and regulating apoptosis, Adropin may help to mitigate the adverse effects of oxidative stress, which is often elevated in chronic conditions such as heart failure.

 Safety, caveats, and what we don't yet know

While the study presents promising findings regarding the effects of Adropin in a preclinical model, it is essential to note that this research is still in the early stages. The long-term safety of Adropin supplementation, particularly in older adults or those with existing health conditions, has not been fully established. Further studies are needed to explore the effects of Adropin in diverse populations and to determine optimal dosing strategies. Additionally, the translation of these findings from animal models to human subjects requires careful consideration and further investigation.

 Bottom line

Adropin shows potential in mitigating oxidative stress and improving heart function in HFpEF, indicating its possible therapeutic role in enhancing longevity and quality of life for affected individuals.

 Related questions

 Does Adropin have a role in metabolic regulation during aging?

Research suggests that Adropin may improve metabolic regulation, potentially benefiting older adults by enhancing glucose and lipid metabolism, which are often impaired with age.

 Can Adropin influence heart health in older populations?

Given its role in improving cardiac function and reducing oxidative stress, Adropin may be beneficial for heart health in older populations, particularly those at risk for heart failure.

 What are the potential therapeutic applications of Adropin?

Adropin may have therapeutic applications in managing conditions like HFpEF and metabolic disorders, highlighting its importance in cardiovascular health and longevity research.

 Source: PubMed · Lipids Health Dis · published 2025-09-02.

## Sources

- PubMed · Lipids Health Dis: https://pubmed.ncbi.nlm.nih.gov/40898254/